Results 191 to 199 of about 2,201,777 (199)

Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer

Journal of Thoracic Oncology, 2020
Wei-Yu Liao, Daniel Stetson, James Chih-Hsin Yang   +2 more
exaly  

MUC1-C: The Occam Razor of Osimertinib Resistance?

Journal of Thoracic Oncology
Anirudh, Yalamanchali, Khaled A, Hassan
openaire   +2 more sources

Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib

Journal of Thoracic Oncology
Jessica Lee, Pasi A Ja Nne, Russell Madison   +2 more
exaly  

USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma

Cancer Letters
Mei Peiyuan
exaly  

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

Cancer Letters
Yong He, Conghua Lu, Caiyu Lin
exaly  

CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway

Life Sciences
Shang-Gin Wu, Jin-Yuan Shih, Yi-Nan Liu
exaly  

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer

Cancer Genetics
Wu Lanxiang, Yaji Li, Chunjie Wen
exaly  

Cholesterol Regulation in the Treatment of Osimertinib-resistant NSCLC: A Review

Journal of Social Science and Humanities
openaire   +1 more source

USE OF QUINAZOLINE COMPOUND IN OVERCOMING OSIMERTINIB DRUG RESISTANCE

openaire   +1 more source